Avenue Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.55 M
- Revenue Growth -18.49%
- Profit Growth -9.93%
- Ebitda -114.96%
- Net Worth 3.55%
- Total Assets -7.32%
About Avenue Life Sciences
Avenue Life Sciences Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 May 2008 and has a history of 16 years and nine months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.55 M.
Subhash Chandra, Prem Lata, and Sanjeev Jain serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U52310UP2008PTC035228
-
Company No.
035228
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 May 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Avenue Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Jain
|
Managing Director | 14-May-2008 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Subhash Chandra
|
Director | 31-Aug-2018 | Current |
|
Prem Lata
|
Director | 14-May-2008 | Current |
Financial Performance of Avenue Life Sciences.
Avenue Life Sciences Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 18.49% decrease. The company also saw a slight decrease in profitability, with a 9.93% decrease in profit. The company's net worth moved up by a moderate rise of 3.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avenue Life Sciences?
In 2017, Avenue Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Span Laboratories Private LimitedSubhash Chandra is a mutual person
Charges (Loans)
₹0.55 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2010 | Bank Of Baroda | ₹0.55 M | Open |
How Many Employees Work at Avenue Life Sciences?
Unlock and access historical data on people associated with Avenue Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avenue Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avenue Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.